I
CRNX

InceptionR’s Crinetics Pharmaceuticals CRNX Stock Holding History

InceptionR’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Buy
+8,356
New +$311K 0.08% 453
2024
Q3 		– Sell
-8,547
Closed -$383K – 672
2024
Q2 		$383K Buy
8,547
+3,459
+68% +$160K 0.11% 358
2024
Q1 		$238K Buy
+5,088
New +$199K 0.06% 482

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

InceptionR's CRNX Position: Q2 2026 in Review

InceptionR opened a new position in Crinetics Pharmaceuticals (CRNX) in Q2 2026: 8,356 shares worth $313K. The stake represents 0.08% of the portfolio and ranks #453 among its holdings. This is a return to the name: InceptionR previously reported a position in CRNX as recently as Q2 2024.

InceptionR first reported a position in CRNX in Q1 2024 and has held it in 3 quarters since. The position peaked at $383K in Q2 2024. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • InceptionR held 8,356 shares of Crinetics Pharmaceuticals worth $313K as of Q2 2026.
  • Crinetics Pharmaceuticals was a new InceptionR position in Q2 2026.
  • Crinetics Pharmaceuticals made up 0.08% of InceptionR's portfolio in Q2 2026, its #453 holding.
  • InceptionR first reported a position in Crinetics Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • InceptionR's Crinetics Pharmaceuticals position peaked at $383K in Q2 2024.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.